0byt3m1n1

Path: /home/artemisi/mail/.Trash/cur/ [ Home ]
File: 1628698427.M332143P22415.cp05.machighway.com,S=3840,W=3918:2,S
Envelope-to: artemisi@cp05.machighway.com
Delivery-date: Mon, 05 Aug 2019 13:25:26 -0400
Auto-Submitted: auto-replied
From: Mail Delivery System <Mailer-Daemon@cp05.machighway.com>
To: artemisi@cp05.machighway.com
Content-Type: multipart/report; report-type=delivery-status; boundary=1565025926-eximdsn-747008310
MIME-Version: 1.0
Subject: Mail delivery failed: returning message to sender
Message-Id: <E1hugje-0000Pn-Py@cp05.machighway.com>
Date: Mon, 05 Aug 2019 13:25:26 -0400

--1565025926-eximdsn-747008310
Content-type: text/plain; charset=us-ascii

This message was created automatically by mail delivery software.

A message that you sent could not be delivered to one or more of its
recipients. This is a permanent error. The following address(es) failed:

  kirtanadmin@shubalananda.com
    No Such User Here

--1565025926-eximdsn-747008310
Content-type: message/delivery-status

Reporting-MTA: dns; cp05.machighway.com

Action: failed
Final-Recipient: rfc822;kirtanadmin@shubalananda.com
Status: 5.0.0

--1565025926-eximdsn-747008310
Content-type: message/rfc822

Return-path: <artemisi@cp05.machighway.com>
Received: from artemisi by cp05.machighway.com with local (Exim 4.92)
	(envelope-from <artemisi@cp05.machighway.com>)
	id 1hugje-0000PX-LH
	for kirtanadmin@shubalananda.com; Mon, 05 Aug 2019 13:25:26 -0400
To: kirtanadmin@shubalananda.com
Subject: [Shubalananda Kirtan] Please moderate: "Welcome to the new Shubalananda Kirtan website!"
X-PHP-Script: shubalananda.com/wp-comments-post.php for 5.188.211.24
Date: Mon, 5 Aug 2019 17:25:26 +0000
From: WordPress <wordpress@shubalananda.com>
Message-ID: <5f512f251081528017a13692c1f17cba@shubalananda.com>
X-Mailer: PHPMailer 5.2.22 (https://github.com/PHPMailer/PHPMailer)
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8

A new comment on the post "Welcome to the new Shubalananda Kirtan website!" is waiting for your approval
http://shubalananda.com/2017/09/25/welcome-to-the-new-shubalananda-kirtan-website/

Author: Claud (IP address: 5.188.211.24, 5.188.211.24)
Email: james6v@gmail.com
URL: https://fandf.com.ng/viagra-per-nachnahme-ohne-rezept-0b25.pdf
Comment: 
Have you got any qualifications? <a href="https://pixeleator.com/buy-bupropion-online-88e5.pdf" rel="nofollow">buy wellbutrin xl australia</a>  The ODYSSEY Phase 3 trials are designed to create different options to help meet the needs of individual patients. In addition to the up-titration option explored in this study in which patients received a 75 mg Q2W (once every two weeks) dose of alirocumab, and were only be up-titrated to 150 mg Q2W if they were unable to reach prespecified target LDL-C levels, the other ODYSSEY trials are also exploring initiating patients with a 150 mg every two week regimen (intended for patients needing a larger reduction in LDL-C), as well as regimens evaluating alirocumab dosed once every four weeks.

Approve it: http://shubalananda.com/wp-admin/comment.php?action=approve&c=9116#wpbody-content
Trash it: http://shubalananda.com/wp-admin/comment.php?action=trash&c=9116#wpbody-content
Spam it: http://shubalananda.com/wp-admin/comment.php?action=spam&c=9116#wpbody-content
Currently 8,105 comments are waiting for approval. Please visit the moderation panel:
http://shubalananda.com/wp-admin/edit-comments.php?comment_status=moderated#wpbody-content


--1565025926-eximdsn-747008310--